The DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index.
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Open accessAbstract
Tumor cells increase the use of anabolic pathways to satisfy the metabolic requirements associated with a high growth rate. Transformed cells take up and metabolize nutrients such as glucose and glutamine at high levels that support anabolic growth. Oncogenic signaling through the PI3K/Akt and Myc pathways directly control glucose and glutamine uptake, respectively. In order to achieve elevated rates of nucleotide biosynthesis, neoplastic cells must divert carbon from PI3K/Akt-induced glycolytic flux into the nonoxidative branch of the pentose phosphate pathway to generate ribose-5-phosphate. This redirection of glucose catabolism appears to be regulated by cytoplasmic tyrosine kinases. Myc-induced glutamine metabolism also increases the abundance and activity of different rate-limiting enzymes that produce the molecular precursors required for de novo nucleotide synthesis. In this review, we will focus on recent progress in understanding how glucose and glutamine metabolism is redirected by oncogenes in order to support de novo nucleotide biosynthesis during proliferation and how metabolic reprogramming can be potentially exploited in the development of new cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cytosolic glutamine supports nucleotide biosynthesis, which is essential for rapidly proliferating cells30.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Self-citationHypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc882 · Cited by 1,658
Cited by
Sorted by citations
Items 101–200 of 351
Hypoxia drives the assembly of the multienzyme purinosome complex
Doigneaux, C., Pedley, A. M., Mistry, I. N., Papayova, M., Benkovic, S. J., & Tavassoli, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012175 · Cited by 65
Hypoxia and cancer related pathology
Xiong, Q., Liu, B., Ding, M., Zhou, J., Yang, C., & Chen, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.002 · Cited by 71
PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth
Zhang, X., Zhang, X., Li, Y., Shao, Y., Xiao, J., Zhu, G., & Li, F. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.85 · Cited by 67
Emerging roles of nucleotide metabolism in cancer development: progress and prospect
Ma, J., Zhong, M., Xiong, Y., Gao, Z., Wu, Z., Liu, Y., & Hong, X. (2021) · Aging · doi:10.18632/aging.202962 · Cited by 65
Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer
Eastlack, S. C., Dong, S., Ivan, C., & Alahari, S. K. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0851-8 · Cited by 65
Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
Zecchini, V. R., Madhu, B., Russell, R., Pértega‐Gomes, N., Warren, A. Y., Gaude, E., Borlido, J., Stark, R., Zecchini, H. I., Rao, R. B., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201386874 · Cited by 65
Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer
Tian, Y., Xu, T., Huang, J., Zhang, L., Xu, S., Xiong, B., Wang, Y., & Tang, H. (2016) · Scientific Reports · doi:10.1038/srep20790 · Cited by 63
Wawrzyniak, J. A., Bianchi, A., Bshara, W., Mannava, S., Ackroyd, J. J., Bagati, A., Omilian, A. R., Im, M. M., Fedtsova, N. G., Miecznikowski, J. C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.015 · Cited by 66
Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease
Mirtschink, P., & Krek, W. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.011 · Cited by 61
Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids
Duarte, I. F., & Gil, A. M. (2012) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2011.11.002 · Cited by 62
Vernardis, S. I., Terzoudis, K., Panoskaltsis, N., & Mantalaris, A. (2017) · Scientific Reports · doi:10.1038/srep42138 · Cited by 63
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Khatami, F., Payab, M., Sarvari, M., Gilany, K., Larijani, B. A., Arjmand, B., & Tavangar, S. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188661 · Cited by 59
Chalecka, M., Kazberuk, A., Palka, J. A., & Surażyński, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111763 · Cited by 61
SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis
Zhu, T., Wang, Z., Zou, T., Xu, L., Zhang, S., Chen, Y., Chen, C., Zhang, W., Wang, S., Ding, Q., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.769647 · Cited by 56
Oberkersch, R. E., Pontarin, G., Astone, M., Spizzotin, M., Arslanbaeva, L. R., Tosi, G., Panieri, E., Ricciardi, S., Allega, M. F., Brossa, A., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.018 · Cited by 55
ATM Is a Redox Sensor Linking Genome Stability and Carbon Metabolism
Krüger, A., & Ralser, M. (2011) · Science Signaling · doi:10.1126/scisignal.2001959 · Cited by 56
De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer
Singh, A., Ruiz, C. F., Bhalla, K., Haley, J. D., Li, Q. K., Acquaah-Mensah, G. K., Montal, E. D., Sudini, K. R., Skoulidis, F., Wistuba, I. I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800204 · Cited by 60
Agarwal, S., Chakravarthi, B. V. S. K., Behring, M. P., Kim, H., Chandrashekar, D. S., Gupta, N., Bajpai, P., Elkholy, A., Balasubramanya, S. A. H., Hardy, C., et al. (2020) · Cancers · doi:10.3390/cancers12040772 · Cited by 56
Zhao, Z., Lü, J., Han, L., Wang, X., Man, Q., & Liu, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4720-4 · Cited by 53
The effect of immunosuppressive molecules on T-cell metabolic reprogramming
Fernández-Ramos, A. A., Poindessous, V., Marchetti, C., Pallet, N., & Loriot, M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.04.016 · Cited by 53
Plewa, S., Horała, A., Dereziński, P., Klupczyńska, A., Nowak‐Markwitz, E., Matysiak, J., & Kokot, Z. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122727 · Cited by 53
Exploring the role of glucose‑6‑phosphate dehydrogenase in cancer (Review)
Li, R., Wang, W., Yang, Y., & Gu, C. (2020) · Oncology Reports · doi:10.3892/or.2020.7803 · Cited by 52
Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression
Krupenko, S. A., & Krupenko, N. I. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.013 · Cited by 51
Bianchi, A., Wawrzyniak, J. A., Bagati, A., Marvin, E. K., Ackroyd, J. J., Moparthy, S., Bshara, W., Fink, E. E., Foley, C. E., Morozevich, G. E., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.47 · Cited by 50
Methionine coordinates a hierarchically organized anabolic program enabling proliferation
Walvekar, A. S., Srinivasan, R., Gupta, R., & Laxman, S. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-08-0515 · Cited by 50
Bhatia, B., Potts, C. R., Guldal, C. G., Choi, S., Korshunov, A., Pfister, S. M., Kenney, A. M., & Nahle, Z. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0968-6 · Cited by 50
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
Siddiqui, A., Gollavilli, P. N., Schwab, A., Vazakidou, M. E., Ersan, P. G., Ramakrishnan, M., Pluim, D., Coggins, S. A., Saatci, Ö., Annaratone, L., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0289-6 · Cited by 49
Taylor, H. E., Calantone, N., Lichon, D., Hudson, H., Clerc, I., Campbell, E. M., & D’Aquila, R. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107810 · Cited by 48
Ribose‐5‐phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling
Ciou, S., Chou, Y., Liu, Y., Nieh, Y., Lu, J., Huang, S.-F. K., Chou, Y., Cheng, L., Lo, J., Chen, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29361 · Cited by 53
Wu, C., Chou, H., Cheng, C., Li, J., Lin, S., Chen, Y., & Chan, H. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.12.038 · Cited by 49
Cell-Cycle–Dependent Phosphorylation of PRPS1 Fuels Nucleotide Synthesis and Promotes Tumorigenesis
Jing, X., Wang, X.-J., Zhang, T., Zhu, W., Fang, Y., Wu, H., Liu, X., Ma, D., Ji, X., Jiang, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2486 · Cited by 47
Shiroki, T., Yokoyama, M., Tanuma, N., Maejima, R., Tamai, K., Yamaguchi, K., Oikawa, T., Noguchi, T., Miura, K., Fujiya, T., et al. (2017) · Cancer Science · doi:10.1111/cas.13211 · Cited by 50
Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition
Michalopoulou, E., Auciello, F. R., Bulusu, V., Strachan, D., Campbell, A. D., Tait-Mulder, J., Karim, S. A., Morton, J. P., Sansom, O. J., & Kamphorst, J. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.080 · Cited by 50
Revisiting the Warburg Effect: Diet‐Based Strategies for Cancer Prevention
Tran, Q., Lee, H., Kim, C., Kong, G., Gong, N., Kwon, S. H., Park, J., Kim, S., & Park, J. (2020) · BioMed Research International · doi:10.1155/2020/8105735 · Cited by 51
An extended Myc network contributes to glucose homeostasis in cancer and diabetes
Christopher, W. P. (2011) · Frontiers in bioscience · doi:10.2741/3848 · Cited by 48
ATIC-Associated De Novo Purine Synthesis Is Critically Involved in Proliferative Arterial Disease
Ma, Q., Yang, Q., Xu, J., Zhang, X., Kim, D. S., Liu, Z., Da, Q., Mao, X., Zhou, Y., Cai, Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058901 · Cited by 46
Leung, R. W. H., & Lee, T. K. (2022) · Cancers · doi:10.3390/cancers14215468 · Cited by 50
MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway
Huang, J., Qin, Y., Lin, C., Huang, X., & Zhang, F. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10135 · Cited by 45
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Arora, A., Singh, S. P., Bhatt, A. N., Pandey, S., Sandhir, R., & Dwarakanath, B. S. R. (2015) · Translational Oncogenomics · doi:10.4137/tog.s29652 · Cited by 43
Salama, S. A., Mohammad, M. A., Diaz‐Arrastia, C., Kamel, M., Kilic, G. S., Ndofor, B. T., Abdelbaki, M. S., & Theiler, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2639 · Cited by 43
Wu, T., Yang, M., Wei, H.-F., He, S.-H., Wang, S.-C., & Ji, G. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/968083 · Cited by 44
Wang, S., Peng, Z., Wang, S., Yang, L., Chen, Y., Kong, X., Song, S., Pei, P., Tian, C., Yan, H., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0008-8 · Cited by 45
Matsuoka, Y., Yoshida, R., Kawahara, K., Sakata, J., Arita, H., Nkashima, H., Takahashi, N., Hirayama, M., Nagata, M., Hirosue, A., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00776-w · Cited by 43
Sloan, E., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910377489 · Cited by 42
Yu, L., Hu, Q., & Gu, J. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00708-y · Cited by 41
Yu, L., Zhou, S., Hu, Q., Chen, X., & Gu, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60903-9 · Cited by 41
Fan, Y., Xue, H., Li, Z., Huo, M., Gao, H., & Guan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345522 · Cited by 40
Trejo‐Solís, C., Silva‐Adaya, D., Serrano-García, N., Magaña-Maldonado, R., Jiménez‐Farfán, D., Ferreira-Guerrero, E., Cruz-Salgado, A., & Castillo‐Rodríguez, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417633 · Cited by 44
Systems biology of the metabolic network regulated by the Akt pathway
Mosca, E., Barcella, M., Alfieri, R. R., Bevilacqua, A., Canti, G. L., & Milanesi, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.004 · Cited by 40
Calvisi, D. F., Frau, M., Tomasi, M. L., Feo, F., & Pascale, R. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.003 · Cited by 40
Regulation of local GTP availability controls RAC1 activity and cell invasion
Bianchi, A., Wolff, D. W., Marston, D. J., Deng, Z., Han, Z., Moparthy, S., Wombacher, R. M., Mussell, A. L., Shen, S., Chen, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26324-6 · Cited by 44
Sandulache, V. C., & Myers, J. N. (2011) · Head & Neck · doi:10.1002/hed.21664 · Cited by 38
Diagnostic and prognostic value of thymidylate synthase expression in breast cancer
Song, S., Tian, B., Zhang, M., Gao, X., Liu, J., Liu, P., & Li, J. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13415 · Cited by 39
Cai, J., Sun, X., Guo, H., Qu, X., Huang, H., Yu, C. J., Wu, H., Gao, Y., Kong, X., & Xia, Q. (2020) · Oncogenesis · doi:10.1038/s41389-020-00287-7 · Cited by 37
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 44
Razungles, J., Cavaillès, V., Jalaguier, S., & Teyssier, C. (2013) · médecine/sciences · doi:10.1051/medsci/20132911020 · Cited by 50
Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer
Dong, X., Tang, H., Hess, K. R., Abbruzzese, J. L., & Li, D. (2010) · Cancer · doi:10.1002/cncr.25612 · Cited by 35
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
Poli, G., Ceni, E., Armignacco, R., Ercolino, T., Canu, L., Baroni, G., Nesi, G., Galli, A., Mannelli, M., & Luconi, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3299 · Cited by 36
A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic
Majd, N., Sumita, K., Yoshino, H., Chen, D., Terakawa, J., Daikoku, T., Kofuji, S., Curry, R. C., Wise-Draper, T. M., Warnick, R. E., et al. (2014) · Journal of Cancer Research · doi:10.1155/2014/423401 · Cited by 35
One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
Rizzo, A., Napoli, A., Roggiani, F., Tomassetti, A., Bagnoli, M., & Mezzanzanica, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072092 · Cited by 36
Liu, B., Huang, Z., Chen, X., See, Y.-X., Chen, Z.-K., & Yao, H. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00659-7 · Cited by 35
Pelletier, J., Riaño‐Canalias, F., Almacellas, E., Mauvezin, C., Samino, S., Feu, S., Menoyo, S., Domostegui, A., Garcia‐Cajide, M., Salazar, R., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103838 · Cited by 36
Jayachandran, A., Lo, P., Chüeh, A. C., Prithviraj, P., Molania, R., Dávalos-Salas, M., Anaka, M., Walkiewicz, M., Cebon, J. S., & Behren, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2185-5 · Cited by 35
Fujiwara, T., Hirooka, S., Ohbayashi, R., Onuma, R., & Miyagishima, S. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.20.00469 · Cited by 33
Up-regulation of vitamin B1 homeostasis genes in breast cancer
Zastre, J. A., Hanberry, B. S., Sweet, R. L., McGinnis, A. C., Venuti, K., Bartlett, M. G., & Govindarajan, R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.02.002 · Cited by 33
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
Cetinbas, N. M., Daugaard, M., Mullen, A. R., Hajee, S., Rotblat, B., Lopez, A., Li, A.-P., DeBerardinis, R. J., & Sørensen, P. (2014) · Oncogene · doi:10.1038/onc.2014.316 · Cited by 32
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33
Hsieh, Y.-C., Tedeschi, P. M., Lawal, R. A., Banerjee, D., Scotto, K. W., Kerrigan, J. E., Lee, K.-C., Johnson-Farley, N. N., Bertino, J. R., & Abali, E. E. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080218 · Cited by 32
Bailleul, J., Ruan, Y., Abdulrahman, L., Scott, A. J., Yazal, T., Sung, D., Park, K., Hoang, H., Nathaniel, J., Chu, F., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad103 · Cited by 32
Induction of oxidative metabolism by the p38α/MK2 pathway
Trempolec, N., Muñoz, J. P., Slobodnyuk, K., Marín, S., Cascante, M., Zorzano, A., & Nebreda, Á. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11309-7 · Cited by 30
Elevated pentose phosphate pathway flux supports appendage regeneration
Patel, J. H., Ong, D. J., Williams, C., Callies, K., & Wills, A. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111552 · Cited by 30
Campos, M., & Albrecht, L. V. (2023) · Cancers · doi:10.3390/cancers16010016 · Cited by 33
Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
Long, Z., Zhou, J., Xie, K., Wu, Z., Yin, H., Daria, V., Tian, J., Zhang, N., Li, L., Zhao, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00981 · Cited by 29
Kong, D., Li, S., Du, Z., Liu, C., Liu, B.-Q., Li, C. R., Zong, Z., & Wang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6396 · Cited by 29
Mitochondrial–cell cycle cross-talk drives endoreplication in heart disease
Bischof, C., Mirtschink, P., Yuan, T., Wu, M., Zhu, C., Kaur, J., Pham, M. D., Gonzalez-Gonoggia, S., Hammer, M., Rogg, E.-M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7964 · Cited by 27
The roles of molecular chaperones in regulating cell metabolism
Binder, M. J., & Pedley, A. M. (2023) · FEBS Letters · doi:10.1002/1873-3468.14682 · Cited by 32
Bioactive Food Components and Cancer‐Specific Metabonomic Profiles
Kim, Y. S., & Milner, J. A. (2010) · BioMed Research International · doi:10.1155/2011/721213 · Cited by 26
Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer
Dong, X., Li, Y., Chang, P., Tang, H., Hess, K. R., Abbruzzese, J. L., & Li, D. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0247 · Cited by 27
A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates
Mercier, K., Al‐Jazrawe, M., Poon, R. W. M., Acuff, Z., & Alman, B. A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18921-7 · Cited by 28
De novo pyrimidine biosynthesis in the oomycete plant pathogen Phytophthora infestans
García-Bayona, L., Garavito, M. F., Lozano, G. L., Vasquez, J. J., Myers, K. L., Fry, W. E., Bernal, A., Zimmermann, B. H., & Restrepo, S. (2013) · Gene · doi:10.1016/j.gene.2013.12.009 · Cited by 25
The conditional role of inflammation in pregnancy and cancer
Soeters, P. B., & Grimble, R. F. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.07.010 · Cited by 24
Intersections between mitochondrial sirtuin signaling and tumor cell metabolism
Herrera, K. N. G., Lee, J. J., & Haigis, M. C. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1031879 · Cited by 25
Expression and Knockdown Analysis of Glucose Phosphate Isomerase in Chicken Primordial Germ Cells1
Rengaraj, D., Lee, S. I., Yoo, M., Kim, T. H., Song, G., & Han, J. Y. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.101345 · Cited by 24
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C., Chari, R., Li, A., Zhang, W., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00229-2 · Cited by 21
One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review
Ghannad‐Zadeh, K., & Das, S. (2021) · Cancers · doi:10.3390/cancers13123067 · Cited by 23
Transcriptome study digs out BMP2 involved in adipogenesis in sheep tails
Jin, M., Fei, X., Li, T., Lu, Z., Chu, M., Di, R., He, X., Wang, X., & Wei, C. (2022) · BMC Genomics · doi:10.1186/s12864-022-08657-8 · Cited by 23
Liu, D., Jin, X., Yu, G., Wang, M., Liu, L., Zhang, W., Jia Rui, W. U., Wang, F., Yang, J., Luo, Q. F., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.08.013 · Cited by 23
Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase‐1
Thirant, C., Varlet, P., Lipecka, J., Gall, M. L., Broussard, C., Chafey, P., Studler, J., Lacombe, J., Lions, S., Guillaudeau, A., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201000646 · Cited by 22
Boutard, N., Białas, A., Sabiniarz, A., Guzik, P., Banaszak, K., Biela, A. P., Bień, M., Buda, A., Bugaj, B., Cieluch, E., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800569 · Cited by 22
Wang, T., Wang, L., Wang, G., & Zhuang, Y. (2020) · Bioresources and Bioprocessing · doi:10.1186/s40643-020-00325-7 · Cited by 21
Serum Metabolomics of Burkitt Lymphoma Mouse Models
Yang, F., Du, J., Zhang, H., Ruan, G., Xiang, J., Wang, L., Sun, H., Guan, A., Shen, G., Liu, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170896 · Cited by 22
Tsugawa, H., & Suzuki, H. (2018) · Springer eBooks · doi:10.1007/978-981-13-1120-8_4 · Cited by 22
Combination therapy targeting cancer metabolism
Wenger, J. B., Chun, S. Y., Dang, D. T., Luesch, H., & Dang, L. H. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.008 · Cited by 21
PRPS1 silencing reverses cisplatin resistance in human breast cancer cells
He, M., Chao, L., & You, Y.-P. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0106 · Cited by 21
Metabolomics and lipidomics in non-small cell lung cancer
Shi, W., Cheng, Y., Zhu, H., & Zhao, L. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117823 · Cited by 21
Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa
Arrighi, N., Bodei, S., Lucente, A., Michel, M. C., Zani, D., Simeone, C., Cunico, S. C., Spano, P., & Sigala, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.009 · Cited by 20
Time-resolved proteomics of adenovirus infected cells
Valdés, A., Zhao, H., Pettersson, U., & Lind, S. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204522 · Cited by 20
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells
Wong, V. K. W., Dong, H., Xu, L., Bai, L., Jiang, Z., Guo, Y., Kong, A. T., Wang, R., Kam, R. K. T., Law, B. Y. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6934 · Cited by 21
Tsun, A., Chen, Z., & Li, B. (2011) · Protein & Cell · doi:10.1007/s13238-011-1114-2 · Cited by 20
Metabolic disturbance of short- and medium-chain chlorinated paraffins to zebrafish larva
Chen, S., Ren, X., Yu, Y., Cheng, L., Ding, G., Yang, H., Zhang, H., Chen, J., & Geng, N. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171372 · Cited by 19
Metadata
- Authors
- Tong, X., Zhao, F., & Thompson, C. B.
- Affiliations
- Abramson Cancer Center (US)
- Corresponding author
- Tong, Xuemei
- Zhao, Fangping
- Thompson, Craig B
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 32-37
- ISSN
- 0959-437X (ISSN-L)
- PMC
- PMC2707261
- OpenAlex
- W2002869675
- Cited by
- 351
- References
- 56
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 22 · 2023: 20 · 2022: 22 · 2021: 24 · 2020: 32 · 2019: 20 · 2018: 18 · 2017: 15 · 2016: 17 · 2015: 26 · 2014: 17 · 2013: 15 · 2012: 33
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Genetics & Development (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA092660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, metabolic reprogramming, PI3K/Akt signaling, c-Myc, glucose metabolism, glutamine metabolism, pentose phosphate pathway, ribose-5-phosphate, glycolysis, oncogenic signaling, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glucose, Glutamine, Glycolysis, Humans, Models, Biological, Neoplasms, Pentose Phosphate Pathway, Ribosemonophosphates, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review